NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

冠狀病毒治療藥的市場規模:各藥物類別、給藥途徑、流通管道、地區 - 佔有率,預測,機會分析(2020∼2027)

Coronavirus Treatment Drugs Market, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 979997
出版日期 內容資訊 英文 175 Pages
商品交期: 2-3個工作天內
價格
冠狀病毒治療藥的市場規模:各藥物類別、給藥途徑、流通管道、地區 - 佔有率,預測,機會分析(2020∼2027) Coronavirus Treatment Drugs Market, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月21日內容資訊: 英文 175 Pages
簡介

含新型冠狀病毒所使用的治療藥的冠狀病毒治療藥,有皮質類固醇,抗病毒,單株抗體,激化酵素抑制劑等,各種藥物類別,冠狀病毒通常依重度,中度,輕度等症狀程度治療。主要企業,為了強化全球市場的地位,著重產品核可的取得。

本報告提供全球冠狀病毒治療藥市場的相關調查,市場機會和趨勢,成長及阻礙因素,各藥物類別、給藥途徑、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場展望

  • 報告概要
  • 市場定義和範圍
  • 摘要整理
  • 市場概述:各類藥物
  • 市場概述:各給藥途徑
  • 市場概述:各流通管道
  • 市場概述:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 成長要素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的發展
  • 新產品的銷售/核准
  • 合併收購方案
  • 法規方案
  • 開發平台分析
  • 流行病學
  • PEST分析
  • 償付

第4章 COVID-19大流行的影響

  • 對COVID-19的政府舉措
  • COVID-19患者的治療管理

第5章 市場分析:各類藥物(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢

第6章 市場分析:各給藥途徑(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢

第7章 市場分析:各流通管道(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 市場區隔趨勢

第8章 市場分析:各地區(2016-2027)

  • 簡介
  • 市場佔有率分析(2020&2027)
  • 與前一年同期比較成長分析(2017-2027)
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭情形

  • 企業簡介
    • Serum Institute of India
    • Pfizer Inc.
    • AstraZeneca plc.
    • Bharat Biotech International Limited
    • Cadila Healthcare Limited
    • Johnson & Johnson
    • Moderna
    • GlaxoSmithKline plc
    • CanSino Biologics
    • Sinovac Biotech
    • Novavax, Inc.
    • Glenmark Pharmaceuticals Limited
    • Dr. Reddy's Laboratories
    • Merck & Co., Inc.
目錄

Title:
Coronavirus Treatment Drugs Market, by Drug Class (Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

The coronavirus treatment drugs comprises therapeutics which are used for treatment of the novel coronavirus. There are various drug classes such as corticosteroids, anti-viral, monoclonal antibodies, Kinase inhibitors which can be used for treatment of the coronavirus. The coronavirus is generally treated depending on severity of symptoms such as severe, moderate and mild. The common symptoms of coronavirus are cold, fever, breathlessness, headache, and stomach pain.

Market Dynamics

Key players are focusing on obtaining product approvals in order to strengthen their position in the global coronavirus treatment drugs market. For instance, in June 2020, Glenmark Pharmaceuticals Limited, a pharmaceutical company in India, launched the first orally administered tablet, Fabiflu, for the treatment of patients suffering from mild and moderate symptoms of COVID-19. Fabiflu is available as a 200 mg tablet, has been priced at US$ 1 per tablet. A strip of 34 tablets will cost US$ 47.55 to the patients in India.

Furthermore, key companies are focusing on inorganic strategies such agreements in order to strengthen their position in the global coronavirus treatments drugs market. For instance, in September 2020, Dr Reddy's Laboratories, an Indian pharmaceutical company, announced the launch of Remdesivir under the brand name, Redyx, for the Indian market. The launch of Redyx for treatment for COVID-19 is because of licensing agreement of Dr Reddy Laboratories with Gilead Sciences Inc. which grants Dr Reddy's Laboratories the right to register, manufacture and sell Remdesivir, as a potential treatment for COVID-19 in 127 countries including India.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global coronavirus treatment drugs market. The market for coronavirus treatment drugs is segmented on the basis of drug class, route of administration, distribution channel, and region.
  • This report provides in-depth analysis of the global coronavirus treatment drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global coronavirus treatment drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global coronavirus treatment drugs market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global coronavirus treatment drugs market.

Detailed Segmentation:

  • Global Coronavirus Treatment Drugs Market, By Drug Class:
    • Corticosteroids
    • Anti-viral
    • Monoclonal Antibodies
    • Kinase Inhibitors
    • Others
  • Global Coronavirus Treatment Drugs Market, By Route of Administration:
    • Oral
    • Intravenous
  • Global Coronavirus Treatment Drugs Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Coronavirus Treatment Drugs Market, By Region:
    • North America
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Drug Class:
      • Corticosteroids
      • Anti-viral
      • Monoclonal Antibodies
      • Kinase Inhibitors
      • By Route of Administration:
      • Oral
      • Intravenous
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Serum Institute of India*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • AstraZeneca plc.
    • Bharat Biotech International Limited
    • Cadila Healthcare Limited
    • Johnson & Johnson
    • Moderna
    • GlaxoSmithKline plc.
    • CanSino Biologics
    • Sinovac Biotech
    • Novavax, Inc.
    • Glenmark Pharmaceuticals Limited
    • Dr. Reddy's Laboratories
    • Merck & Co., Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunities
  • Impact Analysis
  • Key Developments
  • New Product Launches/Approvals
  • Merger-Acquisition Scenario
  • Regulatory Scenario
  • Pipeline Analysis
  • Epidemiology
  • PEST Analysis
  • Reimbursement

4. Global Coronavirus Treatment Drugs Market - Impact of COVID-19 Pandemic

  • Government Initiatives To Combat COVID-19
  • Therapeutic Management of COVID-19 Patients

5. Global Coronavirus Treatment Drugs Market, By Drug Class, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Anti-viral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Monoclonal Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Kinase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

6. Global Coronavirus Treatment Drugs Market, By Route of Administration, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

7. Global Coronavirus Treatment Drugs Market, By Distribution Channel, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Mn)

8. Global Coronavirus Treatment Drugs Market, By Region, 2016-2027 (US$ Mn)

  • Introduction
  • Market Share Analysis, By Country, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Countries, 2017-2027
  • North America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Drug Class, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Route of Administration, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • Serum Institute of India
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AstraZeneca plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bharat Biotech International Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cadila Healthcare Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Moderna
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CanSino Biologics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sinovac Biotech
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novavax, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Glenmark Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies